Aspergillus Pneumonia Successfully Treated with Itraconazole in a Patient with Systemic Lupus Erythematosus
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The case of a patient with systemic lupus erythematosus who developed pneumonia caused by Aspergillus fumigatus is described. She was treated with itraconazole 200 mg twice daily, with a rapid response. After a follow-up period of 5 years no recurrence of the infection has been detected. To our knowledge this is the first report on the use of itraconazole in patients with systemic lupus erythematosus. Considering the poor prognosis associated with Aspergillus pneumonia in patients with systemic lupus erythematosus, we believe that itraconazole constitutes a safe and effective alternative to amphotericin B in these patients.
References
1.
Hellmann D, Petri M
. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore). 1987; 66(5):341-8.
DOI: 10.1097/00005792-198709000-00002.
View
2.
Gerson S, Talbot G, Hurwitz S, Strom B, Lusk E, Cassileth P
. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med. 1984; 100(3):345-51.
DOI: 10.7326/0003-4819-100-3-345.
View
3.
Anaissie E
. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis. 1992; 14 Suppl 1:S43-53.
DOI: 10.1093/clinids/14.supplement_1.s43.
View
4.
Kimura M, Udagawa S, Shoji A, Kume H, Iimori M, Satou T
. Pulmonary aspergillosis due to Aspergillus terreus combined with staphylococcal pneumonia and hepatic candidiasis. Mycopathologia. 1990; 111(1):47-53.
DOI: 10.1007/BF02277302.
View
5.
Nived O, Sturfelt G, Wollheim F
. Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. Q J Med. 1985; 55(218):271-87.
View